-+ 0.00%
-+ 0.00%
-+ 0.00%

Ginkgo Bioworks joins Waterfall Scientific-led ARPA-H consortium to build autonomous RNA drug manufacturing system

PUBT·09/10/2026 12:05:28
Listen to the news
Ginkgo Bioworks joins Waterfall Scientific-led ARPA-H consortium to build autonomous RNA drug manufacturing system
  • Ginkgo Bioworks joined Waterfall Scientific’s ESCALATOR consortium under ARPA-H’s GIVE program to develop benchtop manufacturing for individualized RNA medicines.
  • Subcontract award totals up to USD 17.5 million to build automation hardware and control software for a continuous-flow, autonomous RNA production system.
  • Scope includes integrating four manufacturing modules with in-line quality control, targeting automated quality release at single-patient scale.
  • Consortium includes Ansa Biotechnologies, Polymorphic Biosciences, Tensentric, Volta Labs; project begins with a technical kickoff later this month.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ginkgo Bioworks Holdings Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202609100800BIZWIRE_USPR_____20260910_BW477067) on September 10, 2026, and is solely responsible for the information contained therein.